Literature DB >> 21896778

Induction of the alternative NF-κB pathway by lymphotoxin αβ (LTαβ) relies on internalization of LTβ receptor.

Corinne Ganeff1, Caroline Remouchamps, Layla Boutaffala, Cécile Benezech, Géraldine Galopin, Sarah Vandepaer, Fabrice Bouillenne, Sandra Ormenese, Alain Chariot, Pascal Schneider, Jorge Caamaño, Jacques Piette, Emmanuel Dejardin.   

Abstract

Several tumor necrosis factor receptor (TNFR) family members activate both the classical and the alternative NF-κB pathways. However, how a single receptor engages these two distinct pathways is still poorly understood. Using lymphotoxin β receptor (LTβR) as a prototype, we showed that activation of the alternative, but not the classical, NF-κB pathway relied on internalization of the receptor. Further molecular analyses revealed a specific cytosolic region of LTβR essential for its internalization, TRAF3 recruitment, and p100 processing. Interestingly, we found that dynamin-dependent, but clathrin-independent, internalization of LTβR appeared to be required for the activation of the alternative, but not the classical, NF-κB pathway. In vivo, ligand-induced internalization of LTβR in mesenteric lymph node stromal cells correlated with induction of alternative NF-κB target genes. Thus, our data shed light on LTβR cellular trafficking as a process required for specific biological functions of NF-κB.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21896778      PMCID: PMC3209329          DOI: 10.1128/MCB.05033-11

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  61 in total

1.  BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF.

Authors:  J S Thompson; S A Bixler; F Qian; K Vora; M L Scott; T G Cachero; C Hession; P Schneider; I D Sizing; C Mullen; K Strauch; M Zafari; C D Benjamin; J Tschopp; J L Browning; C Ambrose
Journal:  Science       Date:  2001-08-16       Impact factor: 47.728

2.  Dynasore, a cell-permeable inhibitor of dynamin.

Authors:  Eric Macia; Marcelo Ehrlich; Ramiro Massol; Emmanuel Boucrot; Christian Brunner; Tomas Kirchhausen
Journal:  Dev Cell       Date:  2006-06       Impact factor: 12.270

3.  TRAF3 controls activation of the canonical and alternative NFkappaB by the lymphotoxin beta receptor.

Authors:  Pradeep Bista; Weike Zeng; Sarah Ryan; Veronique Bailly; Jeffrey L Browning; Matvey E Lukashev
Journal:  J Biol Chem       Date:  2010-02-25       Impact factor: 5.157

4.  Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation.

Authors:  M Delhase; M Hayakawa; Y Chen; M Karin
Journal:  Science       Date:  1999-04-09       Impact factor: 47.728

5.  Specificity of TRAF3 in its negative regulation of the noncanonical NF-kappa B pathway.

Authors:  Jeannie Q He; Supriya K Saha; Jason R Kang; Brian Zarnegar; Genhong Cheng
Journal:  J Biol Chem       Date:  2006-12-11       Impact factor: 5.157

6.  Control of canonical NF-kappaB activation through the NIK-IKK complex pathway.

Authors:  Brian Zarnegar; Soh Yamazaki; Jeannie Q He; Genhong Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-21       Impact factor: 11.205

7.  Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase.

Authors:  R Shinkura; K Kitada; F Matsuda; K Tashiro; K Ikuta; M Suzuki; K Kogishi; T Serikawa; T Honjo
Journal:  Nat Genet       Date:  1999-05       Impact factor: 38.330

8.  Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK.

Authors:  Brian J Zarnegar; Yaya Wang; Douglas J Mahoney; Paul W Dempsey; Herman H Cheung; Jeannie He; Travis Shiba; Xiaolu Yang; Wen-Chen Yeh; Tak W Mak; Robert G Korneluk; Genhong Cheng
Journal:  Nat Immunol       Date:  2008-11-09       Impact factor: 25.606

9.  Clathrin-mediated endocytosis in AP-2-depleted cells.

Authors:  Alison Motley; Nicholas A Bright; Matthew N J Seaman; Margaret S Robinson
Journal:  J Cell Biol       Date:  2003-09-01       Impact factor: 10.539

10.  A structural explanation for the binding of endocytic dileucine motifs by the AP2 complex.

Authors:  Bernard T Kelly; Airlie J McCoy; Kira Späte; Sharon E Miller; Philip R Evans; Stefan Höning; David J Owen
Journal:  Nature       Date:  2008-12-18       Impact factor: 49.962

View more
  25 in total

Review 1.  The Tumor Necrosis Factor Family: Family Conventions and Private Idiosyncrasies.

Authors:  David Wallach
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-10-01       Impact factor: 10.005

2.  Lyn regulates inflammatory responses in Klebsiella pneumoniae infection via the p38/NF-κB pathway.

Authors:  Xuefeng Li; Xikun Zhou; Yan Ye; Yi Li; Jiaxin Li; Breanna Privratsky; Erxi Wu; Hongwei Gao; Canhua Huang; Min Wu
Journal:  Eur J Immunol       Date:  2013-12-16       Impact factor: 5.532

3.  Attenuated TRAF3 Fosters Activation of Alternative NF-κB and Reduced Expression of Antiviral Interferon, TP53, and RB to Promote HPV-Positive Head and Neck Cancers.

Authors:  Jialing Zhang; Tony Chen; Xinping Yang; Hui Cheng; Stephan S Späth; Paul E Clavijo; Jianhong Chen; Christopher Silvin; Natalia Issaeva; Xiulan Su; Wendell G Yarbrough; Christina M Annunziata; Zhong Chen; Carter Van Waes
Journal:  Cancer Res       Date:  2018-06-19       Impact factor: 12.701

4.  Chloroquine reduces osteoclastogenesis in murine osteoporosis by preventing TRAF3 degradation.

Authors:  Yan Xiu; Hao Xu; Chen Zhao; Jinbo Li; Yoshikazu Morita; Zhenqiang Yao; Lianping Xing; Brendan F Boyce
Journal:  J Clin Invest       Date:  2013-12-09       Impact factor: 14.808

Review 5.  The non-canonical NF-κB pathway in immunity and inflammation.

Authors:  Shao-Cong Sun
Journal:  Nat Rev Immunol       Date:  2017-06-05       Impact factor: 53.106

Review 6.  Targeting signaling factors for degradation, an emerging mechanism for TRAF functions.

Authors:  Xiao-Dong Yang; Shao-Cong Sun
Journal:  Immunol Rev       Date:  2015-07       Impact factor: 12.988

7.  Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer.

Authors:  Rita Das; Jamie Coupar; Paul E Clavijo; Anthony Saleh; Tsu-Fan Cheng; Xinping Yang; Jianhong Chen; Carter Van Waes; Zhong Chen
Journal:  Mol Carcinog       Date:  2018-11-28       Impact factor: 4.784

8.  NIK promotes tissue destruction independently of the alternative NF-κB pathway through TNFR1/RIP1-induced apoptosis.

Authors:  L Boutaffala; M J M Bertrand; C Remouchamps; G Seleznik; F Reisinger; M Janas; C Bénézech; M T Fernandes; S Marchetti; F Mair; C Ganeff; A Hupalowska; J-E Ricci; B Becher; J Piette; P Knolle; J Caamano; P Vandenabeele; M Heikenwalder; E Dejardin
Journal:  Cell Death Differ       Date:  2015-06-05       Impact factor: 15.828

9.  TRAF molecules in cell signaling and in human diseases.

Authors:  Ping Xie
Journal:  J Mol Signal       Date:  2013-06-13

10.  Lymphotoxin-β receptor signaling through NF-κB2-RelB pathway reprograms adipocyte precursors as lymph node stromal cells.

Authors:  Cécile Bénézech; Emma Mader; Guillaume Desanti; Mahmood Khan; Kyoko Nakamura; Andrea White; Carl F Ware; Graham Anderson; Jorge H Caamaño
Journal:  Immunity       Date:  2012-08-30       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.